Full Text View
Tabular View
No Study Results Posted
Related Studies
Familial Colorectal Cancer Registry in Hispanics (PURIFICAR)
This study is currently recruiting participants.
Verified by University of Puerto Rico, September 2009
First Received: June 24, 2009   Last Updated: September 10, 2009   History of Changes
Sponsor: University of Puerto Rico
Collaborators: University of Puerto Rico Comprehensive Cancer Center
National Cancer Institute (NCI)
University of Southern California
Information provided by: University of Puerto Rico
ClinicalTrials.gov Identifier: NCT00927680
  Purpose

Colorectal cancer (CRC) is the second leading cause of cancer in Puerto Rico (PR) accounting for approximately 1,500 individuals annually, which represent 12% of all cancer cases in the island. The genetic epidemiology of CRC among Hispanic populations is not well studied, hence studies focused on large, well defined ethnic groups such as Puerto Ricans, are clearly warranted. The first step towards evaluating the molecular, environmental, and genetic epidemiology of CRC in PR is to establish a population-based familial CRC registry. The following specific aims have been proposed:

Specific Aim 1: To prospectively identify and recruit approximately 300 CRC probands from two distinct geographical areas in PR (Metropolitan and Southern Region). From each proband the investigators will obtain a pedigree extended to second-degree relatives and cousins. Assuming 10% will be positive for a family history of CRC, the investigators will then recruit all 30 probands with a family history of CRC and a sample of 15 family-history negative probands and obtain: paraffin-embedded tumors blocks, blood samples, risk factor and food frequency questionnaires.

Specific Aim 2: To prospectively identify and recruit selected relatives (parents, grandparents, and same generation relatives - cousins and siblings) from the 45 probands identified in Specific Aim 1. In addition, for siblings and cousins of probands (i.e. relatives in the same generation as the proband), the investigators will obtain risk factor and food frequency questionnaires, and for colorectal cancer cases, tumor blocks and pathology reports of their cancers.

Specific Aim 3: To estimate from this pilot study the following parameters: (a) response rate of probands and their selected relatives; (b) response rate of participants for each data item; (c) family history of CRC and other cancers; (d) number of living first- and second-degree relatives and cousins of probands; (e) number of these relatives who live in the same household and region/municipality; (f) prevalence/distribution of selected risk factors from the administered questionnaires.


Condition
Colorectal Cancer

Study Type: Observational
Study Design: Family-Based, Prospective
Official Title: Familial Colorectal Cancer In Puerto Rico: A Feasibility Study

Resource links provided by NLM:


Further study details as provided by University of Puerto Rico:

Primary Outcome Measures:
  • We will recruit all 30 probands with a family history of CRC and a sample of 15 family-history negative probands and obtain the following: paraffin-embedded tumors blocks, blood samples, risk factor and food frequency questionnaires. [ Time Frame: 2 years ] [ Designated as safety issue: No ]
  • We will study the relatives of the CRC probands. [ Time Frame: 2 years ] [ Designated as safety issue: No ]
  • We will study the following parameters that will help us plan the larger population-based study such as: response rate of probands and their selected relatives, response rate of participants (probands and relatives), etcetera. [ Time Frame: 2 years ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples With DNA

Biospecimen Description:

Tumor blocks (colorectal tumors) and blood samples


Estimated Enrollment: 300
Study Start Date: July 2007
Groups/Cohorts
CRC cases with family history of CRC
CRC cases without family history of CRC

  Eligibility

Ages Eligible for Study:   21 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Probands will be ascertained from the Puerto Rico Central Cancer Registry (PRCCR), from the monthly report of incident colorectal cancer cases that will be provide by Dr. Nayda Figueroa, co-investigator in this pilot project. We will follow a passive consent approval from probands identified through the PRCCC. The PRCCR allows patient contact after written notification with the probands physician in record. Physicians are notified about the intent of the investigator to contact his/her patient unless physician denies access to the patient. If the physician does not deny access to contact his/her patient, a letter will be sent to the probands informing them about the study and inviting them to contact the primary investigator.

Criteria

Inclusion criteria:

  • patients with pathologic diagnosis of colorectal cancer (ICD codes 180-189,199,209)
  • who are 21 years of age or older
  • without previous history of colorectal cancer
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00927680

Contacts
Contact: Marcia R. Cruz-Correa, MD, PhD 787-766-1240 marcia.cruz1@upr.edu
Contact: Yaritza Diaz-Algorri, MS 787-766-1240 yaritza.diaz7@upr.edu

Locations
Puerto Rico
University of Puerto Rico Comprehensive Cancer Center Recruiting
San Juan, Puerto Rico, 00936
Contact: Marcia R. Cruz-Correa, MD, PhD     787-766-1240     marcia.cruz1@upr.edu    
Contact: Yaritza Diaz-Algorri, MS     787-766-1240     yaritza.diaz7@upr.edu    
Principal Investigator: Marcia R. Cruz-Correa, MD, PhD            
Sub-Investigator: Reynold Lopez-Enriquez, MD            
Sub-Investigator: Edna M. Mora-Pinero, MD            
Sub-Investigator: Rafael A. Mosquera-Fernandez, MD            
Sub-Investigator: Carlos G. Micames-Caceres, MD            
Sub-Investigator: Nayda Figueroa-Valles, MD            
Sponsors and Collaborators
University of Puerto Rico
University of Puerto Rico Comprehensive Cancer Center
University of Southern California
Investigators
Principal Investigator: Marcia R. Cruz-Correa, MD, PhD University of Puerto Rico Comprehensive Cancer Center
Principal Investigator: Robert Haile, DrPH University of Southern California
  More Information

No publications provided

Responsible Party: University of Puerto Rico Comprehensive Cancer Center ( Marcia R. Cruz-Correa, MD, PhD )
Study ID Numbers: R03CA130034 NCI
Study First Received: June 24, 2009
Last Updated: September 10, 2009
ClinicalTrials.gov Identifier: NCT00927680     History of Changes
Health Authority: United States: Institutional Review Board

Keywords provided by University of Puerto Rico:
Colorectal Cancer
Familial Colorectal Cancer
Genetics
Hispanics

Additional relevant MeSH terms:
Neoplasms
Digestive System Diseases
Neoplasms by Site
Digestive System Neoplasms
Gastrointestinal Diseases
Colonic Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Rectal Diseases
Intestinal Neoplasms
Colorectal Neoplasms

ClinicalTrials.gov processed this record on February 08, 2010